Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pancreatitis

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 234 articles:
HTML format



Single Articles


    July 2021
  1. JOLISSAINT JS, Reyngold M, Bassmann J, Seier KP, et al
    Local Control and Survival after Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma with Vascular Involvement.
    Ann Surg. 2021 Jul 16. pii: 00000658-900000000-93409.
    PubMed     Abstract available


  2. MAATMAN TK, McGuire SP, Flick KF, Madison MK, et al
    Outcomes in Endoscopic and Operative Transgastric Pancreatic Debridement.
    Ann Surg. 2021 Jul 7. pii: 00000658-900000000-93434.
    PubMed     Abstract available


  3. YEO TP, Fogg RW, Shimada A, Marchesani N, et al
    The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery Clinic.
    Ann Surg. 2021 Jul 2. pii: 00000658-900000000-93452.
    PubMed     Abstract available


    June 2021
  4. HESTER CA, Kothari AN, Mason M, Maxwell J, et al
    Surgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients with Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race.
    Ann Surg. 2021 Jun 25. pii: 00000658-900000000-93456.
    PubMed     Abstract available


  5. DAI M, Liu Q, Xing C, Tian X, et al
    Early Drain Removal is Safe in Patients With Low or Intermediate Risk of Pancreatic Fistula After Pancreaticoduodenectomy: A Multicenter, Randomized Controlled Trial.
    Ann Surg. 2021 Jun 11. pii: 00000658-900000000-93510.
    PubMed     Abstract available


    April 2021
  6. BANNONE E, Marchegiani G, Balduzzi A, Procida G, et al
    Early and Sustained Elevation in Serum Pancreatic Amylase Activity: A Novel Predictor of Morbidity after Pancreatic Surgery.
    Ann Surg. 2021 Apr 30. pii: 00000658-900000000-93565.
    PubMed     Abstract available


  7. GIULIANI T, De Pastena M, Paiella S, Marchegiani G, et al
    Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis.
    Ann Surg. 2021 Apr 14. pii: 00000658-900000000-93588.
    PubMed     Abstract available


  8. HABIB JR, Kinny-Koster B, Bou-Samra P, Alsaad R, et al
    Surgical Decision Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant Chemotherapy.
    Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93602.
    PubMed     Abstract available


  9. MENG H, Wang S, Liu J, Zhao X, et al
    Laparoscopic Pancreaticoduodenectomy with Transanal Specimen Extraction for Periampullary Tumors.
    Ann Surg. 2021 Apr 7. pii: 00000658-900000000-93576.
    PubMed     Abstract available


  10. HACKERT T, Buchler MW
    Respone to: Comment on Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004872.
    PubMed    


  11. LINDEMANN J, Toit LD, Krige J, Jonas E, et al
    Comment on: Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004877.
    PubMed    


    March 2021
  12. SCHUH F, Mihaljevic AL, Probst P, Trudeau MT, et al
    A Simple Classification Of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery (ISGPS).
    Ann Surg. 2021 Mar 12. doi: 10.1097/SLA.0000000000004855.
    PubMed     Abstract available


  13. MARCHEGIANI G, Perri G, Burelli A, Zoccatelli F, et al
    High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis.
    Ann Surg. 2021 Mar 4. doi: 10.1097/SLA.0000000000004840.
    PubMed     Abstract available


  14. HANK T, Hinz U, Reiner T, Malleo G, et al
    A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer.
    Ann Surg. 2021 Mar 4. doi: 10.1097/SLA.0000000000004845.
    PubMed     Abstract available


    February 2021
  15. LOOS M, Hackert T, Buchler MW
    Response to Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93709.
    PubMed    


  16. REAMES BN, Ejaz A, Weiss MJ
    Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93707.
    PubMed    


    January 2021
  17. BEGER HG, Mayer B, Vasilescu C, Poch B, et al
    Long-term Metabolic Morbidity and Steatohepatosis Following Standard Pancreatic Resections and Parenchyma-sparing, Local Extirpations for Benign Tumor: A Systematic Review and Meta-analysis.
    Ann Surg. 2021 Jan 15. doi: 10.1097/SLA.0000000000004757.
    PubMed     Abstract available


  18. VAN DEN BERG FF, Issa Y, Vreijling JP, Lerch MM, et al
    Whole-Exome Sequencing Identifies SLC52A1 and ZNF106 Variants as Novel Genetic Risk Factors for (Early) Multiple-Organ Failure in Acute Pancreatitis.
    Ann Surg. 2021;Publish Ahead of Print.
    PubMed     Abstract available


  19. ADDEO P, Averous G, Bachellier P
    Response to Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?"
    Ann Surg. 2021 Jan 1. pii: 00000658-900000000-93782.
    PubMed    


    December 2020
  20. QING Z, Liu ZY, Chen QY, Huang CM, et al
    Comment on: Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Dec 29. doi: 10.1097/SLA.0000000000004734.
    PubMed    


  21. HEWITT DB, Nissen N, Hatoum H, Musher B, et al
    A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects with Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
    Ann Surg. 2020 Dec 22. doi: 10.1097/SLA.0000000000004669.
    PubMed     Abstract available


  22. GIBOR U, Perry Z, Netz U, Kirshtein B, et al
    Circulating Cell-free DNA in Patients with Acute Biliary Pancreatitis: Association with Disease Markers and Prolonged Hospitalization Time-A Prospective Cohort Study.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  23. SUGUMAR K, Hue JJ, Ahorukomeye P, Rothermel LD, et al
    Defining Common Features in High Impact and Highly Cited Journal Articles on Pancreatic Tumors: An Analysis of 1044 Studies over the Past Decade.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  24. DE GEUS SWL, Hachey KJ, Nudel JD, Ng SC, et al
    Volume of Pancreas-Adjacent Operations Favorably Influences Pancreaticoduodenectomy Outcomes at Lower Volume Pancreas Centers.
    Ann Surg. 2020 Dec 2. doi: 10.1097/SLA.0000000000004432.
    PubMed     Abstract available


  25. VERSTEIJNE E, Suker M, Groen JV, Besselink MG, et al
    External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer: Outcome of Eligible But Non-Randomized Patients.
    Ann Surg. 2020 Dec 2. doi: 10.1097/SLA.0000000000004364.
    PubMed     Abstract available


    November 2020
  26. HUNGER R, Mantke R
    Outcome Quality Beyond the Mean - An Analysis of 43,231 Pancreatic Surgical Procedures Related to Hospital Volume.
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004315.
    PubMed     Abstract available


  27. LOF S, Korrel M, Besselink MG, Abu Hilal M, et al
    Response to Comment on "Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004279.
    PubMed    


  28. CHEN B, Li G, Cheng W, Chen M, et al
    Comment On: Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes.
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004621.
    PubMed    


  29. ZYROMSKI NJ, Maatman TK
    Response to Letter to Editor Regarding: "Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes" (Ann Surg 2020 Jul 7. Online Ahead of Print; PMID: 32649468).
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004622.
    PubMed    


  30. ROBERTSON FP, Ravikumar R, Wigmore SJ
    Comment on: Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004536.
    PubMed    


  31. ZHANG XP, Zhao GD, Liu R
    Comment On "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?"
    Ann Surg. 2020 Nov 16. doi: 10.1097/SLA.0000000000004410.
    PubMed    


  32. RAMIREZ-MALDONADO E, Gordo SL, Pueyo EM, Sanchez-Garcia A, et al
    Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI trial).
    Ann Surg. 2020 Nov 13. doi: 10.1097/SLA.0000000000004596.
    PubMed     Abstract available


  33. VAN DONGEN JC, Suker M, Versteijne E, Bonsing BA, et al
    Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial).
    Ann Surg. 2020 Nov 12. doi: 10.1097/SLA.0000000000004313.
    PubMed     Abstract available


  34. MALLEO G, Maggino L, Qadan M, Marchegiani G, et al
    Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2020 Nov 9. doi: 10.1097/SLA.0000000000004552.
    PubMed     Abstract available


    October 2020
  35. HUANG L
    Response to the: Comment on "Optimal Number of Examined Lymph Node May Depend on Age in Patients with Pancreatic Adenocarcinoma".
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004449.
    PubMed    


  36. CRIPPA S, Pergolini I, Javed AA, Honselmann KC, et al
    Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004464.
    PubMed     Abstract available


  37. DATTA J, Wilson GC, D'Angelica MI, Katz MH, et al
    A Call for Caution in Overinterpreting Exceptional Outcomes Following Radical Surgery for Pancreatic Cancer: Let the Data Speak.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004471.
    PubMed    


  38. MAATMAN TK, Ceppa EP, Fogel EL, Easler JJ, et al
    Biliary Stricture after Necrotizing Pancreatitis: An Underappreciated Challenge.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004470.
    PubMed     Abstract available


  39. CHAWLA A, Qadan M, Castillo CF, Wo JY, et al
    Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004585.
    PubMed     Abstract available


  40. XU HX, Li S, Xu SS, Liu L, et al
    Comments on "Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients with Localized Pancreatic Cancer".
    Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004538.
    PubMed    


  41. TAKAHASHI S, Ohno I, Ikeda M, Konishi M, et al
    Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer: A Phase II Open-Label Multicenter Prospective Trial (JASPAC05).
    Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004535.
    PubMed     Abstract available


  42. SCHULICK RD, Oba A, Del Chiaro M
    Response to the Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines".
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004275.
    PubMed    


    September 2020
  43. HU HJ, Cheng NS, Li FY
    Comment on: Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study.
    Ann Surg. 2020 Sep 29. doi: 10.1097/SLA.0000000000004283.
    PubMed    


    August 2020
  44. WUSTER C, Shi H, Kuhlbrey CM, Biesel EA, et al
    Pancreatic Inflammation and Proenzyme Activation Are Associated With Clinically Relevant Postoperative Pancreatic Fistulas After Pancreas Resection.
    Ann Surg. 2020 Aug 21. doi: 10.1097/SLA.0000000000004257.
    PubMed     Abstract available


  45. TAKAI E, Nakamura H, Chiku S, Kubo E, et al
    Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer.
    Ann Surg. 2020 Aug 18. doi: 10.1097/SLA.0000000000004213.
    PubMed     Abstract available


  46. DREYER SB, Pinese M, Jamieson NB, Scarlett CJ, et al
    Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.
    Ann Surg. 2020;272:366-376.
    PubMed     Abstract available


  47. HONSELMANN KC, Pergolini I, Castillo CF, Deshpande V, et al
    Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.
    Ann Surg. 2020;272:357-365.
    PubMed     Abstract available


  48. OBA A, Stoop TF, Lohr M, Hackert T, et al
    Global Survey on Pancreatic Surgery During the COVID-19 Pandemic.
    Ann Surg. 2020;272:e87-e93.
    PubMed     Abstract available


    July 2020
  49. KATO H, Kishiwada M, Hayasaki A, Chipaila J, et al
    Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma: CEA Level Before Operation is a Significant Prognostic Indicator in Patients With Locally Advanced Pancreatic Cancer Treated With Neoadjuvant Therapy Followe
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004148.
    PubMed     Abstract available


  50. WEI MY, Hua J, Yu XJ, Shi S, et al
    Comment on "Prognosis-Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines".
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004291.
    PubMed    


  51. KONE LB, Torres C, Banulescu M, Maker VK, et al
    Perioperative Broad-spectrum Antibiotics are Associated With Decreased Surgical Site Infections Compared to 1st-3rd Generation Cephalosporins After Open Pancreaticoduodenectomy in Patients With Jaundice or a Biliary Stent.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004216.
    PubMed     Abstract available


  52. ARRINGTON AK, O'Grady C, Schaefer K, Khreiss M, et al
    Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004181.
    PubMed     Abstract available


  53. AHMAD SA, Duong M, Sohal DPS, Gandhi NS, et al
    Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004155.
    PubMed     Abstract available


  54. MERCHANT N
    Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer.
    Ann Surg. 2020 Jul 16. doi: 10.1097/SLA.0000000000004191.
    PubMed    


  55. SEPPALA TT, Zimmerman JW, Sereni E, Plenker D, et al
    Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer.
    Ann Surg. 2020 Jul 9. doi: 10.1097/SLA.0000000000004200.
    PubMed     Abstract available


  56. EVANS DB
    The Complexity of Neoadjuvant Therapy for Operable Pancreatic Cancer: Lessons Learned From SWOG S1505.
    Ann Surg. 2020 Jul 9. doi: 10.1097/SLA.0000000000004131.
    PubMed    


  57. DAAMEN LA, Groot VP, Besselink MG, Bosscha K, et al
    Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis.
    Ann Surg. 2020 Jul 8. doi: 10.1097/SLA.0000000000004093.
    PubMed     Abstract available


  58. POULTSIDES GA
    Pancreatic Cancer Prognostication: From Trousseau to Thrombelastography.
    Ann Surg. 2020 Jul 8. doi: 10.1097/SLA.0000000000004139.
    PubMed    


  59. STROBEL O, Lorenz P, Hinz U, Gaida M, et al
    Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds?
    Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004147.
    PubMed     Abstract available


  60. MAATMAN TK, Nicolas ME, Roch AM, Lewellen KA, et al
    Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes.
    Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004149.
    PubMed     Abstract available


  61. ROTH S, Bose P, Alhamdani MSS, Mustafa SA, et al
    Noninvasive Discrimination of Low and High-risk Pancreatic Intraductal Papillary Mucinous Neoplasms.
    Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004066.
    PubMed     Abstract available


  62. HANK T, Sandini M, Ferrone CR, Ryan DP, et al
    A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer: The PANAMA-score.
    Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004143.
    PubMed     Abstract available


    June 2020
  63. LOOS M, Kester T, Klaiber U, Mihaljevic AL, et al
    Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve.
    Ann Surg. 2020 Jun 12. doi: 10.1097/SLA.0000000000004054.
    PubMed     Abstract available


  64. TRUDEAU MT, Casciani F, Ecker BL, Maggino L, et al
    The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy.
    Ann Surg. 2020 Jun 11. doi: 10.1097/SLA.0000000000004068.
    PubMed     Abstract available


  65. ZHANG XF, Xue F, Wu Z, Lopez-Aguiar AG, et al
    Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2020 Jun 4. doi: 10.1097/SLA.0000000000004039.
    PubMed     Abstract available


  66. NEYTON LPA, Zheng X, Skouras C, Doeschl-Wilson A, et al
    Molecular Patterns in Acute Pancreatitis Reflect Generalizable Endotypes of the Host Response to Systemic Injury in Humans.
    Ann Surg. 2020 Jun 2. doi: 10.1097/SLA.0000000000003974.
    PubMed     Abstract available


  67. FERRONE CR, Ryan DP
    Pancreatic Cancer: A Time to Change.
    Ann Surg. 2020;271:1003-1004.
    PubMed    


    May 2020
  68. ZHANG YY, Xu J, Yu XJ, Shi S, et al
    Comment on "Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma".
    Ann Surg. 2020 May 29. doi: 10.1097/SLA.0000000000003989.
    PubMed    


  69. PERRI G, Katz MHG
    Response to the Comment on "Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma".
    Ann Surg. 2020 May 11. doi: 10.1097/SLA.0000000000003987.
    PubMed    


  70. KANDIMALLA R, Shimura T, Mallik S, Sonohara F, et al
    Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2020 May 8. doi: 10.1097/SLA.0000000000003945.
    PubMed     Abstract available


  71. OBA A, Stoop TF, Lohr M, Hackert T, et al
    Global Survey on Pancreatic Surgery During the COVID-19 Pandemic.
    Ann Surg. 2020 May 1. doi: 10.1097/SLA.0000000000004006.
    PubMed    


    April 2020
  72. HACKERT T, Klaiber U, Hinz U, Buchler MW, et al
    Response to the Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer".
    Ann Surg. 2020;271:e109-e110.
    PubMed    


    March 2020
  73. ZHENG ZJ, Chen YH, Tan CL, Liu XB, et al
    Comment on "Optimal Number of Examined Lymph Node May Dependent on Age in Patients With Pancreatic Adenocarcinoma".
    Ann Surg. 2020 Mar 20. doi: 10.1097/SLA.0000000000003811.
    PubMed    


  74. HUA J, Shi S, Xu J, Wei M, et al
    Expression Patterns and Prognostic Value of DNA Damage Repair Proteins in Resected Pancreatic Neuroendocrine Neoplasms.
    Ann Surg. 2020 Mar 20. doi: 10.1097/SLA.0000000000003884.
    PubMed     Abstract available


  75. OBA A, Croce C, Hosokawa P, Meguid C, et al
    Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines.
    Ann Surg. 2020 Mar 6. doi: 10.1097/SLA.0000000000003859.
    PubMed     Abstract available


    February 2020
  76. STRIJKER M, Mackay TM, Bonsing BA, Bruno MJ, et al
    Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group.
    Ann Surg. 2020 Feb 20. doi: 10.1097/SLA.0000000000003779.
    PubMed    


    January 2020
  77. KLEIN HJ, Niggemann P, Buehler PK, Lehner F, et al
    Pancreatic Stone Protein Predicts Sepsis in Severely Burned Patients Irrespective of Trauma Severity: A Monocentric Observational Study.
    Ann Surg. 2020 Jan 14. doi: 10.1097/SLA.0000000000003784.
    PubMed     Abstract available


  78. RICCI C, Pagano N, Ingaldi C, Frazzoni L, et al
    Treatment for Infected Pancreatic Necrosis Should be Delayed, Possibly Avoiding an Open Surgical Approach: A Systematic Review and Network Meta-analysis.
    Ann Surg. 2020 Jan 14. doi: 10.1097/SLA.0000000000003767.
    PubMed     Abstract available


  79. MOAVEN O, Clark CJ, Russell GB, Votanopoulos KI, et al
    Optimal Adjuvant Treatment Approach After Upfront Resection of Pancreatic Cancer: Revisiting the Role of Radiation Based on Pathologic Features.
    Ann Surg. 2020 Jan 6. doi: 10.1097/SLA.0000000000003770.
    PubMed     Abstract available


    December 2019
  80. PERRI G, Prakash L, Qiao W, Varadhachary GR, et al
    Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma.
    Ann Surg. 2019 Dec 31. doi: 10.1097/SLA.0000000000003763.
    PubMed     Abstract available


  81. LOF S, Korrel M, van Hilst J, Moekotte AL, et al
    Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study.
    Ann Surg. 2019 Dec 10. doi: 10.1097/SLA.0000000000003717.
    PubMed     Abstract available


  82. REN W, Ashley SW
    Comment on Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003667.
    PubMed    


  83. BALZANO G, Pecorelli N, Falconi M, Reni M, et al
    Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer" What Is Good for the Surgeon Is Just as Good for the Patient?
    Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003655.
    PubMed    


  84. POWERS BD, Fulp W, Dhahri A, DePeralta DK, et al
    The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis.
    Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003706.
    PubMed     Abstract available


  85. ZHANG B, Lee GC, Qadan M, Fong ZV, et al
    Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma.
    Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003503.
    PubMed     Abstract available


  86. RANGELOVA E, Orsini N, Del Chiaro M
    Response to Comment on "Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer".
    Ann Surg. 2019;270:e139-e141.
    PubMed    


  87. HUA J, Shi S, Yu X
    Comment on "Operable Pancreatic Cancer: Are We in an Era of Individualized Neoadjuvant Therapy?"
    Ann Surg. 2019;270:e94-e95.
    PubMed    


  88. DOKMAK S
    Comment on "Comparison of Perioperative Outcomes Between the Laparoscopic and Open Approach for Pancreaticoduodenectomy: Can We Compare the Results of the Laparoscopic Approach With Bad Results of the Open Approach?"
    Ann Surg. 2019;270:e91-e92.
    PubMed    


    October 2019
  89. BEANE JD, Borrebach JD, Zureikat AH, Kilbane EM, et al
    Optimal Pancreatic Surgery: Are We Making Progress in North America?
    Ann Surg. 2019 Oct 28. doi: 10.1097/SLA.0000000000003628.
    PubMed     Abstract available


  90. GIRGIS MD, Zenati MS, King JC, Hamad A, et al
    Oncologic Outcomes After Robotic Pancreatic Resections Are Not Inferior to Open Surgery.
    Ann Surg. 2019 Oct 28. doi: 10.1097/SLA.0000000000003615.
    PubMed     Abstract available


  91. HACKERT T, Klaiber U, Buchler MW
    Response: Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer" What Is Good for the Surgeon Is Just as Good for the Patient? The Case of Unresectable Pancreatic Cancer After
    Ann Surg. 2019 Oct 22. doi: 10.1097/SLA.0000000000003652.
    PubMed    


  92. SHI Y, Wang W, Qiu W, Zhao S, et al
    Learning Curve From 450 Cases of Robot-Assisted Pancreaticoduocectomy in a High-Volume Pancreatic Center: Optimization of Operative Procedure and a Retrospective Study.
    Ann Surg. 2019 Oct 22. doi: 10.1097/SLA.0000000000003664.
    PubMed     Abstract available


  93. UEMURA J, Okano K, Oshima M, Suto H, et al
    Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2019 Oct 9. doi: 10.1097/SLA.0000000000003624.
    PubMed     Abstract available


  94. SANDINI M, Paiella S, Cereda M, Angrisani M, et al
    Perioperative Interstitial Fluid Expansion Predicts Major Morbidity Following Pancreatic Surgery: Appraisal by Bioimpedance Vector Analysis.
    Ann Surg. 2019 Oct 4. doi: 10.1097/SLA.0000000000003536.
    PubMed     Abstract available


    September 2019
  95. MAZZAFERRO V, Virdis M, Sposito C, Cotsoglou C, et al
    Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula: A Prospective Clinical Study.
    Ann Surg. 2019 Sep 26. doi: 10.1097/SLA.0000000000003514.
    PubMed     Abstract available


  96. PULVIRENTI A, Javed AA, Landoni L, Jamieson NB, et al
    Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2019 Sep 24. doi: 10.1097/SLA.0000000000003579.
    PubMed     Abstract available


  97. MUECK KM, Wei S, Pedroza C, Bernardi K, et al
    Gallstone Pancreatitis: Admission Versus Normal Cholecystectomy-a Randomized Trial (Gallstone PANC Trial).
    Ann Surg. 2019;270:519-527.
    PubMed     Abstract available


    August 2019
  98. REAMES BN, Blair AB, Krell RW, Groot VP, et al
    Management of Locally Advanced Pancreatic Cancer: Results of an International Survey of Current Practice.
    Ann Surg. 2019 Aug 21. doi: 10.1097/SLA.0000000000003568.
    PubMed     Abstract available


  99. HUANG L, Jansen L, Balavarca Y, van der Geest L, et al
    Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
    Ann Surg. 2019 Aug 13. doi: 10.1097/SLA.0000000000003558.
    PubMed     Abstract available


    July 2019
  100. ZHANG XF, Xue F, Dong DH, Lopez-Aguiar AG, et al
    New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.
    Ann Surg. 2019 Jul 26. doi: 10.1097/SLA.0000000000003478.
    PubMed     Abstract available


  101. MIZUNO S, Kato H, Yamaue H, Fujii T, et al
    Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer: A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Ann Surg. 2019 Jul 26. doi: 10.1097/SLA.0000000000003487.
    PubMed     Abstract available


  102. MAGGINO L, Schmidt A, Kading A, Westermark S, et al
    Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study.
    Ann Surg. 2019 Jul 24. doi: 10.1097/SLA.0000000000003508.
    PubMed     Abstract available


  103. BACHMANN K, Melling N, Groteluschen R, Fleischauer A, et al
    Morphologic Factors Predict Pain Relief Following Pancreatic Head Resection in Chronic Pancreatitis Description of the Chronic Pancreatitis Pain Relief (CPPR) Score.
    Ann Surg. 2019 Jul 23. doi: 10.1097/SLA.0000000000003439.
    PubMed     Abstract available


  104. MACEDO FI, Ryon E, Maithel SK, Lee RM, et al
    Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer.
    Ann Surg. 2019 Jul 5. doi: 10.1097/SLA.0000000000003468.
    PubMed     Abstract available


  105. ZAIDI MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, et al
    A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients.
    Ann Surg. 2019 Jul 5. doi: 10.1097/SLA.0000000000003461.
    PubMed     Abstract available


  106. PERRI G, Prakash L, Wang H, Bhosale P, et al
    Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer.
    Ann Surg. 2019 Jul 3. doi: 10.1097/SLA.0000000000003442.
    PubMed     Abstract available


  107. VAN ROESSEL S, Mackay TM, van Dieren S, van der Schelling GP, et al
    Textbook Outcome: Nationwide Analysis of a Novel Quality Measure in Pancreatic Surgery.
    Ann Surg. 2019 Jul 3. doi: 10.1097/SLA.0000000000003451.
    PubMed     Abstract available


  108. NEWTON AD, Predina JD, Shin MH, Frenzel-Sulyok LG, et al
    Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection.
    Ann Surg. 2019;270:12-20.
    PubMed     Abstract available


  109. BOUVET M, Lwin TM, Hoffman RM
    RE: "Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection".
    Ann Surg. 2019;270:21-22.
    PubMed    


    June 2019
  110. KIRKEGARD J, Mortensen FV, Cronin-Fenton D
    Comment on "Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer".
    Ann Surg. 2019 Jun 26. doi: 10.1097/SLA.0000000000003422.
    PubMed    


  111. PITT HA
    Benchmark, Textbook or Optimal Pancreatic Surgery?
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003377.
    PubMed    


  112. PETRUCCIANI N, Antolino L, Moschetta G, Ramacciato G, et al
    Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma".
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003372.
    PubMed    


  113. GROOT VP, Gemenetzis G, Blair AB, Rivero-Soto RJ, et al
    Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2019;269:1154-1162.
    PubMed     Abstract available


  114. MAGGINO L, Malleo G, Bassi C, Allegrini V, et al
    Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal.
    Ann Surg. 2019;269:1146-1153.
    PubMed     Abstract available


    May 2019
  115. NEOPTOLEMOS JP, Ghaneh P, Kleeff J, Halloran CM, et al
    Response to: Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma." By Niccolo Petrucciani, MD, PhD, FACS, Laura Antolino, MD, Giovanni Mosch
    Ann Surg. 2019 May 9. doi: 10.1097/SLA.0000000000003371.
    PubMed    


    April 2019
  116. POVES I
    Response to Comment on "Comparison of Perioperative Outcomes Between the Laparoscopic and Open Approach for Pancreaticoduodenectomy. Can We Compare the Results of the Laparoscopic Approach With Bad Results of the Open Approach?"
    Ann Surg. 2019 Apr 26. doi: 10.1097/SLA.0000000000003343.
    PubMed    


  117. SWORDS DS, Mulvihill SJ, Brooke BS, Stoddard GJ, et al
    County-level Variation in Use of Surgery and Cancer-specific Survival for Stage I-II Pancreatic Adenocarcinoma.
    Ann Surg. 2019 Apr 8. doi: 10.1097/SLA.0000000000003236.
    PubMed     Abstract available


  118. NICKEL F, Haney CM, Kowalewski KF, Probst P, et al
    Laparoscopic Versus Open Pancreaticoduodenectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Ann Surg. 2019 Apr 8. doi: 10.1097/SLA.0000000000003309.
    PubMed     Abstract available


  119. TRUTY MJ, Kendrick ML, Nagorney DM, Smoot RL, et al
    Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer.
    Ann Surg. 2019 Apr 2. doi: 10.1097/SLA.0000000000003284.
    PubMed     Abstract available


  120. RANGELOVA E, Wefer A, Persson S, Valente R, et al
    Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer: A Single Institution Experience.
    Ann Surg. 2019 Apr 2. doi: 10.1097/SLA.0000000000003301.
    PubMed     Abstract available


  121. MANRAI M, Kochhar R
    Response to the Comment on "Outcome of Acute Pancreatic and Peripancreatic Collections Occurring in Patients With Acute Pancreatitis".
    Ann Surg. 2019;269:e52-e53.
    PubMed    


  122. BRADLEY EL 3RD
    Comment on "Outcome of Acute Pancreatic and Peripancreatic Collections Occurring in Patients With Acute Pancreatitis".
    Ann Surg. 2019;269:e51-e52.
    PubMed    


    March 2019
  123. KLAIBER U, Schnaidt ES, Hinz U, Gaida MM, et al
    Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2019 Mar 20. doi: 10.1097/SLA.0000000000003270.
    PubMed     Abstract available


    February 2019
  124. SANCHEZ-VELAZQUEZ P, Muller X, Malleo G, Park JS, et al
    Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons.
    Ann Surg. 2019 Feb 27. doi: 10.1097/SLA.0000000000003223.
    PubMed     Abstract available


  125. KAMARAJAH SK, Sonnenday CJ, Cho CS, Frankel TL, et al
    Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
    Ann Surg. 2019 Feb 25. doi: 10.1097/SLA.0000000000003242.
    PubMed     Abstract available


    January 2019
  126. HONSELMANN KC, Pergolini I, Castillo CF, Deshpande V, et al
    Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.
    Ann Surg. 2019 Jan 18. doi: 10.1097/SLA.0000000000003123.
    PubMed     Abstract available


  127. WANG M, Peng B, Liu J, Yin X, et al
    Practice Patterns and Perioperative Outcomes of Laparoscopic Pancreaticoduodenectomy in China: A Retrospective Multicenter Analysis of 1029 Patients.
    Ann Surg. 2019 Jan 17. doi: 10.1097/SLA.0000000000003190.
    PubMed     Abstract available


    December 2018
  128. VINAULT S, Mariet AS, Le Bras M, Mirallie E, et al
    Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'etude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).
    Ann Surg. 2018 Dec 21. doi: 10.1097/SLA.0000000000003162.
    PubMed     Abstract available


    November 2018
  129. DREYER SB, Pinese M, Jamieson NB, Scarlett CJ, et al
    Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.
    Ann Surg. 2018 Nov 30. doi: 10.1097/SLA.0000000000003143.
    PubMed     Abstract available


  130. ECKER BL, Vollmer CM Jr
    Response: Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy: Response to Goussous and Cunningham.
    Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003121.
    PubMed    


  131. MCCAW ZR, Tian L, Kim DH, Wei LJ, et al
    Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC).
    Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003115.
    PubMed    


  132. MEIJER LL, Garajova I, Caparello C, Le Large TYS, et al
    Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2018 Nov 1. doi: 10.1097/SLA.0000000000003084.
    PubMed     Abstract available


    October 2018
  133. PEA A, Yu J, Marchionni L, Noe M, et al
    Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases.
    Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003022.
    PubMed     Abstract available


  134. TSAI S, George B, Wittmann D, Ritch PS, et al
    Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer.
    Ann Surg. 2018 Oct 11. doi: 10.1097/SLA.0000000000003049.
    PubMed     Abstract available


  135. MATSUDA R, Miyasaka Y, Ohishi Y, Yamamoto T, et al
    Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.
    Ann Surg. 2018 Oct 10. doi: 10.1097/SLA.0000000000003060.
    PubMed     Abstract available


  136. ALLEN CJ, Yakoub D, Macedo FI, Dosch AR, et al
    Long-term Quality of Life and Gastrointestinal Functional Outcomes After Pancreaticoduodenectomy.
    Ann Surg. 2018;268:657-664.
    PubMed     Abstract available


    September 2018
  137. DRIEDGER M, Zyromski NJ, Visser BC, Jester A, et al
    Surgical Transgastric Necrosectomy for Necrotizing Pancreatitis: A Single-stage Procedure for Walled-off Pancreatic Necrosis.
    Ann Surg. 2018 Sep 13. doi: 10.1097/SLA.0000000000003048.
    PubMed     Abstract available


  138. HUGENSCHMIDT H, Labori KJ, Brunborg C, Verbeke CS, et al
    Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
    Ann Surg. 2018 Sep 13. doi: 10.1097/SLA.0000000000003035.
    PubMed     Abstract available


  139. BACHELLIER P, Addeo P, Faitot F, Nappo G, et al
    Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?: A Single Institution's Experience With 118 Patients.
    Ann Surg. 2018 Sep 4. doi: 10.1097/SLA.0000000000003010.
    PubMed     Abstract available


  140. GEMENETZIS G, Groot VP, Yu J, Ding D, et al
    Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status: Results of the Prospective CLUSTER Study.
    Ann Surg. 2018;268:408-420.
    PubMed     Abstract available


    August 2018
  141. SHI S, Liang C, Xu J, Meng Q, et al
    The Strain Ratio as Obtained by Endoscopic Ultrasonography Elastography Correlates With the Stroma Proportion and the Prognosis of Local Pancreatic Cancer.
    Ann Surg. 2018 Aug 3. doi: 10.1097/SLA.0000000000002998.
    PubMed     Abstract available


  142. TSAI S, Christians KK, George B, Ritch PS, et al
    A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2018 Aug 3. doi: 10.1097/SLA.0000000000002957.
    PubMed     Abstract available


    July 2018
  143. BANNONE E, Andrianello S, Marchegiani G, Masini G, et al
    Postoperative Acute Pancreatitis Following Pancreaticoduodenectomy: A Determinant of Fistula Potentially Driven by the Intraoperative Fluid Management.
    Ann Surg. 2018 Jul 12. doi: 10.1097/SLA.0000000000002900.
    PubMed     Abstract available


  144. KUDO A, Akahoshi K, Ito S, Akashi T, et al
    Downregulated Pancreatic Beta Cell Genes Indicate Poor Prognosis in Patients With Pancreatic Neuroendocrine Neoplasms.
    Ann Surg. 2018 Jul 3. doi: 10.1097/SLA.0000000000002911.
    PubMed     Abstract available


    June 2018
  145. ECKER BL, Maggino L, Vollmer CM Jr
    Response to: Managing the High-risk Pancreatic Anastomosis.
    Ann Surg. 2018 Jun 19. doi: 10.1097/SLA.0000000000002883.
    PubMed    


  146. PEDRAZZOLI S, Sperti C
    Prevention of Clinically-relevant Postoperative Pancreatic Fistula After Pancreticoduodenectomy.
    Ann Surg. 2018 Jun 19. doi: 10.1097/SLA.0000000000002878.
    PubMed    


  147. HU HJ, Li FY
    Predictors of Resectability and Survival in Patients with Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment with FOLFIRINOX.
    Ann Surg. 2018 Jun 1. doi: 10.1097/SLA.0000000000002842.
    PubMed    


    May 2018
  148. MUNGROOP TH, Klompmaker S, Groot Koerkamp B, Besselink MG, et al
    Added Value of Body Fat Distribution in Predicting Clinically Significant Pancreatic Fistula in the a-FRS Following Pancreatoduodenectomy Currently Unclear.
    Ann Surg. 2018 May 17. doi: 10.1097/SLA.0000000000002831.
    PubMed    


  149. TORPHY RJ, Friedman C, Halpern A, Chapman BC, et al
    Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers.
    Ann Surg. 2018 May 16. doi: 10.1097/SLA.0000000000002810.
    PubMed     Abstract available



  150. Pancreatic Chymotrypsin Activity Rather Than Amylase Level Better Predicts Postoperative Pancreatic Fistula: Retraction.
    Ann Surg. 2018;267:989.
    PubMed    


    April 2018
  151. HIRONO S, Kawai M, Okada KI, Miyazawa M, et al
    Modified Blumgart Mattress Suture Versus Conventional Interrupted Suture in Pancreaticojejunostomy During Pancreaticoduodenectomy: Randomized Controlled Trial.
    Ann Surg. 2018 Apr 24. doi: 10.1097/SLA.0000000000002802.
    PubMed     Abstract available


  152. KATZ MH, Kim MP, Tzeng CW, Lee JE, et al
    Preoperative Chemoradiation for Borderline Resectable Pancreatic Cancer: The New Standard?
    Ann Surg. 2018 Apr 18. doi: 10.1097/SLA.0000000000002783.
    PubMed    


  153. STERNBY H, Bolado F, Canaval-Zuleta HJ, Marra-Lopez C, et al
    Determinants of Severity in Acute Pancreatitis: A Nation-wide Multicenter Prospective Cohort Study.
    Ann Surg. 2018 Apr 18. doi: 10.1097/SLA.0000000000002766.
    PubMed     Abstract available


  154. GODET T, Guerin R, Verlhac C, Cayot S, et al
    Enteral Versus Total Parenteral Nutrition in Patients Undergoing Pancreaticoduodenectomy: A Randomized Multicenter Controlled Trial (Nutri-DPC): Let's Take a Closer Look at the Pancreas!
    Ann Surg. 2018;267:e70.
    PubMed    


    March 2018
  155. GEMENETZIS G, Groot VP, Blair AB, Laheru DA, et al
    Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection.
    Ann Surg. 2018 Mar 28. doi: 10.1097/SLA.0000000000002753.
    PubMed     Abstract available


  156. CASTILLO CFF
    A Changing Landscape in Pancreatic Cancer.
    Ann Surg. 2018 Mar 23. doi: 10.1097/SLA.0000000000002755.
    PubMed    


  157. GROOT VP, Gemenetzis G, Blair AB, Rivero-Soto RJ, et al
    Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2018 Mar 23. doi: 10.1097/SLA.0000000000002734.
    PubMed     Abstract available


    February 2018
  158. JANG JY, Han Y, Lee H, Kim SW, et al
    Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial.
    Ann Surg. 2018 Feb 16. doi: 10.1097/SLA.0000000000002705.
    PubMed     Abstract available


  159. HACKERT T, Michalski CW, Buchler MW
    Response to the Letter to the Editor "Pancreatic Cancer and FOLFIRINOX: Should We Resect All Responders?" by Neoptolemos and Colleagues.
    Ann Surg. 2018;267:e36-e37.
    PubMed    


  160. NEOPTOLEMOS JP, Halloran CM, Ghaneh P, Kleeff J, et al
    Pancreatic Cancer and FOLFIRINOX: Should We Resect All Responders?
    Ann Surg. 2018;267:e35-e36.
    PubMed    


    January 2018
  161. HE J, Blair AB, Groot VP, Javed AA, et al
    Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?
    Ann Surg. 2018 Jan 12. doi: 10.1097/SLA.0000000000002672.
    PubMed     Abstract available


  162. SHI S, Hua J, Liang C, Meng Q, et al
    Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2018 Jan 12. doi: 10.1097/SLA.0000000000002668.
    PubMed     Abstract available


  163. MAGGINO L, Malleo G, Bassi C, Allegrini V, et al
    Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal.
    Ann Surg. 2018 Jan 12. doi: 10.1097/SLA.0000000000002673.
    PubMed     Abstract available


  164. AZIZ MH, Sideras K, Aziz NA, Mauff K, et al
    The Systemic-Immune-Inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study.
    Ann Surg. 2018 Jan 12. doi: 10.1097/SLA.0000000000002660.
    PubMed     Abstract available


    December 2017
  165. VAN RIJSSEN LB, Gerritsen A, Henselmans I, Sprangers MA, et al
    Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC): An International Delphi Study Among Patients and Health Care Providers.
    Ann Surg. 2017 Dec 19. doi: 10.1097/SLA.0000000000002633.
    PubMed     Abstract available


  166. BRESSAN AK, Aubin JM, Martel G, Dixon E, et al
    Efficacy of a Dual-ring Wound Protector for Prevention of Surgical Site Infections After Pancreaticoduodenectomy in Patients With Intrabiliary Stents: A Randomized Clinical Trial.
    Ann Surg. 2017 Dec 12. doi: 10.1097/SLA.0000000000002614.
    PubMed     Abstract available


  167. MICHELAKOS T, Pergolini I, Castillo CF, Honselmann KC, et al
    Predictors of Resectability and Survival in Patients with Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment with FOLFIRINOX.
    Ann Surg. 2017 Dec 7. doi: 10.1097/SLA.0000000000002600.
    PubMed     Abstract available


  168. KARJULA H, Saarela A, Ohtonen P, Ala-Kokko T, et al
    Long-Term Outcome and Causes of Death for Working-Age Patients Hospitalized Due to Acute Pancreatitis With a Median Follow-Up of 10 Years.
    Ann Surg. 2017 Dec 4. doi: 10.1097/SLA.0000000000002612.
    PubMed     Abstract available


  169. BENDERSKY N, Sulpice L, Farges O
    Reply to the Letter to the Editor "Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: time for a Randomized Controlled Trial? Results of an All-inclusive National Observational Study".
    Ann Surg. 2017;266:e85-e86.
    PubMed    


  170. DE ROOIJ T, van Hilst J, Busch OR, Dijkgraaf MG, et al
    Laparoscopic Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: Time for a Randomized Controlled Trial? Results of an All-inclusive National Observational Study.
    Ann Surg. 2017;266:e84.
    PubMed    


  171. FONG ZV, Fernandez-Del Castillo C
    Early Drain Amylase Value Predicts the Occurrence of Pancreatic Fistula After Pancreaticoduodenectomy.
    Ann Surg. 2017;266:e80.
    PubMed    


  172. TEIXEIRA UF, Goldoni MB, Waechter FL
    Early Drain Amylase Value Predicts the Occurrence of Pancreatic Fistula After Pancreaticoduodenectomy.
    Ann Surg. 2017;266:e79-e80.
    PubMed    


  173. PAAJANEN H
    Reply to "Effect of Laparoscopic Cholecystectomy After Idiopathic Acute Pancreatitis May Be Overestimated".
    Ann Surg. 2017;266:e78.
    PubMed    


  174. MENTULA P
    Effect of Laparoscopic Cholecystectomy After Idiopathic Acute Pancreatitis May Be Overestimated.
    Ann Surg. 2017;266:e77-e78.
    PubMed    


    November 2017
  175. LANDONI L, Marchegiani G, Pollini T, Cingarlini S, et al
    The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution.
    Ann Surg. 2017 Nov 16. doi: 10.1097/SLA.0000000000002594.
    PubMed     Abstract available


  176. JAVED AA, Wolfgang CL
    State of the John L. Cameron, MD Division of Hepatobiliary and Pancreatic Surgery "The Program That John Cameron Built".
    Ann Surg. 2017 Nov 13. doi: 10.1097/SLA.0000000000002587.
    PubMed     Abstract available


  177. YAMASHITA S, Ishizawa T, Mori K, Monden K, et al
    Pancreatic Chymotrypsin Activity Rather Than Amylase Level Better Predicts Postoperative Pancreatic Fistula.
    Ann Surg. 2017 Nov 13. doi: 10.1097/SLA.0000000000002581.
    PubMed     Abstract available


    October 2017
  178. GHANEH P, Kleeff J, Halloran CM, Raraty M, et al
    The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2017 Oct 24. doi: 10.1097/SLA.0000000000002557.
    PubMed     Abstract available


    September 2017
  179. DELPERO JR, Jeune F, Bachellier P, Regenet N, et al
    Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.
    Ann Surg. 2017 Sep 26. doi: 10.1097/SLA.0000000000002432.
    PubMed     Abstract available


  180. WELSCH T, Seifert A, Mussle B, Distler M, et al
    The "T" now Matters: The Eighth Edition of the Union for International Cancer Control Classification of Pancreatic Adenocarcinoma.
    Ann Surg. 2017 Sep 21. doi: 10.1097/SLA.0000000000002531.
    PubMed     Abstract available


  181. FARGES O, Bendersky N, Truant S, Delpero JR, et al
    The Theory and Practice of Pancreatic Surgery in France.
    Ann Surg. 2017 Sep 6. doi: 10.1097/SLA.0000000000002399.
    PubMed     Abstract available


    August 2017
  182. ECKER BL, McMillan MT, Allegrini V, Bassi C, et al
    Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group.
    Ann Surg. 2017 Aug 29. doi: 10.1097/SLA.0000000000002491.
    PubMed     Abstract available


  183. BEGER HG, Poch B, Mayer B, Siech M, et al
    New Onset of Diabetes and Pancreatic Exocrine Insufficiency after Pancreaticoduodenectomy for Benign and Malignant Tumors: A Systematic Review and Meta-analysis of Long-Term Results.
    Ann Surg. 2017 Aug 22. doi: 10.1097/SLA.0000000000002422.
    PubMed     Abstract available


  184. ADAM MA, Roman SA, Sosa JA
    Response to the Letter to the Editor: Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer Is Associated With Increased 30-day Mortality.
    Ann Surg. 2017;266:e26-e27.
    PubMed    


  185. GODHI SA, Nadi PR, Saluja S, Mishra P, et al
    "Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer. Practice Patterns and Short-term Outcomes Among 7061 Patients".
    Ann Surg. 2017;266:e26.
    PubMed    


    July 2017
  186. POST S
    Centralize Pancreatic Surgery Now!
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002442.
    PubMed    


  187. AL EFISHAT MA, Attiyeh MF, Eaton AA, Gonen M, et al
    Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Ann Surg. 2017 Jul 11. doi: 10.1097/SLA.0000000000002421.
    PubMed     Abstract available


  188. SWORDS DS, Mulvihill SJ, Skarda DE, Finlayson SRG, et al
    Hospital-level Variation in Utilization of Surgery for Clinical Stage I-II Pancreatic Adenocarcinoma.
    Ann Surg. 2017 Jul 11. doi: 10.1097/SLA.0000000000002404.
    PubMed     Abstract available


  189. DEMIR IE, Jager C, Schlitter AM, Konukiewitz B, et al
    R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
    Ann Surg. 2017 Jul 7. doi: 10.1097/SLA.0000000000002345.
    PubMed     Abstract available


  190. PULVIRENTI A, Marchegiani G, Pea A, Allegrini V, et al
    Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections.
    Ann Surg. 2017 Jul 3. doi: 10.1097/SLA.0000000000002362.
    PubMed     Abstract available


  191. RAMMOHAN A, Sathyanesan J, Palaniappan R, Govindan M, et al
    Synbiotics in Surgery for Chronic Pancreatitis - A Hobson's Choice?
    Ann Surg. 2017;266:e14-e15.
    PubMed    


  192. ALWA A, Yadav A, Ramesh H
    Synbiotic Therapy With Surgery for Chronic Pancreatitis.
    Ann Surg. 2017;266:e13-e14.
    PubMed    


    June 2017
  193. FONG ZV, Alvino DM, Castillo CF, Nipp RD, et al
    Health-related Quality of Life and Functional Outcomes in 5-year Survivors After Pancreaticoduodenectomy.
    Ann Surg. 2017 Jun 27. doi: 10.1097/SLA.0000000000002380.
    PubMed     Abstract available


  194. ECKER BL, McMillan MT, Asbun HJ, Ball CG, et al
    Characterization and Optimal Management of High-Risk Pancreatic Anastomoses During Pancreatoduodenectomy.
    Ann Surg. 2017 Jun 7. doi: 10.1097/SLA.0000000000002327.
    PubMed     Abstract available


  195. JANG JY, Kang MJ, Kim SW
    Reply to "Different Ideas of Nodal Grouping in Standard and Extended Lymphadenectomy During Pancreaticoduodenectomy for Pancreatic Head Cancer".
    Ann Surg. 2017;265:E74-E75.
    PubMed    


  196. WANG M, Zhu F, Qin R, Peng S, et al
    Which Is the Best Surgical Approach for the Pancreatic Cancer? A Classification of Pancreatic Cancer to Guide Operative Decisions Is Needed.
    Ann Surg. 2017;265:E81-E82.
    PubMed    


  197. PAIELLA S, Butturini G, Bassi C
    Different Ideas of Nodal Grouping in Standard and Extended Lymphadenectomy During Pancreaticoduodenectomy for Pancreatic Head Cancer.
    Ann Surg. 2017;265:E73-E74.
    PubMed    


  198. GODHI SA, Parasar K, Saluja S, Mishra P, et al
    "Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer."
    Ann Surg. 2017;265:E73.
    PubMed    


    May 2017
  199. ALLEN PJ
    Current Controversy of Radiographic Surveillance of Patients With Branch-duct IPMN and Pancreatic Cysts: Commentary on: Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch Duct IPMN After 10 Years of Surveillance.
    Ann Surg. 2017 May 25. doi: 10.1097/SLA.0000000000002315.
    PubMed    


  200. NASSOUR I, Wang SC, Christie A, Augustine MM, et al
    Minimally Invasive Versus Open Pancreaticoduodenectomy: A Propensity-Matched Study From a National Cohort of Patients.
    Ann Surg. 2017 May 8. doi: 10.1097/SLA.0000000000002259.
    PubMed     Abstract available


  201. GUO Q, Hu W
    Reply to Organ Failure and Infection in Necrotizing Pancreatitis: What Are the Predictors of Mortality?
    Ann Surg. 2017;265:e64-e65.
    PubMed    


    April 2017
  202. KRAUTZ C, Nimptsch U, Weber GF, Mansky T, et al
    Effect of Hospital Volume on In-hospital Morbidity and Mortality Following Pancreatic Surgery in Germany.
    Ann Surg. 2017 Apr 4. doi: 10.1097/SLA.0000000000002248.
    PubMed     Abstract available


  203. LUO G, Liu C, Guo M, Cheng H, et al
    Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.
    Ann Surg. 2017;265:800-805.
    PubMed     Abstract available


  204. YIN Z, Ma T, Jin H, Jian Z, et al
    Too Much Water Drowned the Miller-Does Extended Pancreaticoduodenectomy Benefit the Long-term Survival Outcomes in the Treatment of Pancreatic Cancer?
    Ann Surg. 2017;265:e39-e41.
    PubMed    


    March 2017
  205. GROOT VP, Rezaee N, Wu W, Cameron JL, et al
    Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2017 Mar 23. doi: 10.1097/SLA.0000000000002234.
    PubMed     Abstract available


  206. FISHER AV, Fernandes-Taylor S, Campbell-Flohr SA, Clarkson SJ, et al
    30-day Readmission After Pancreatic Resection: A Systematic Review of the Literature and Meta-analysis.
    Ann Surg. 2017 Mar 20. doi: 10.1097/SLA.0000000000002230.
    PubMed     Abstract available


  207. MAGGINO L, Vollmer CM Jr
    Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm?
    Ann Surg. 2017 Mar 16. doi: 10.1097/SLA.0000000000002225.
    PubMed    


  208. MCMILLAN MT, Maggino L, Ecker BL, Vollmer CM Jr, et al
    Reply to Letter: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation".
    Ann Surg. 2017 Mar 14. doi: 10.1097/SLA.0000000000002218.
    PubMed    


  209. TRIPONEZ F, Sadowski SM, Pattou F, Cardot-Bauters C, et al
    Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small </=2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endoc
    Ann Surg. 2017 Mar 3. doi: 10.1097/SLA.0000000000002191.
    PubMed     Abstract available


  210. NELL S, Verkooijen HM, Pieterman CR, de Herder WW, et al
    Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group.
    Ann Surg. 2017 Mar 2. doi: 10.1097/SLA.0000000000002183.
    PubMed     Abstract available


  211. SONBARE DJ
    Organ Failure and Infection in Necrotizing Pancreatitis: What Are the Predictors of Mortality?
    Ann Surg. 2017 Mar 2. doi: 10.1097/SLA.0000000000001205.
    PubMed    


    February 2017
  212. SATOI S, Fujii T, Yanagimoto H, Motoi F, et al
    Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis.
    Ann Surg. 2017;265:397-401.
    PubMed     Abstract available


    January 2017
  213. GEMENETZIS G, Wolfgang CL
    Oncogenesis in Patients With Pancreatic Intraductal Papillary Mucinous Neoplasms: Taking the Thread From the Beginning.
    Ann Surg. 2017 Jan 31. doi: 10.1097/SLA.0000000000002163.
    PubMed    


  214. MORIS D, Felekouras E
    The Oncogenesis in Patients With Pancreatic Intraductal Papillary Mucinous Neoplasms: Taking the Thread From the Beginning.
    Ann Surg. 2017 Jan 24. doi: 10.1097/SLA.0000000000002162.
    PubMed    


  215. FRANKLIN O, Jonsson P, Billing O, Lundberg E, et al
    Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer.
    Ann Surg. 2017 Jan 3. doi: 10.1097/SLA.0000000000002124.
    PubMed     Abstract available


  216. GENC CG, Jilesen AP, Partelli S, Falconi M, et al
    A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2017 Jan 3. doi: 10.1097/SLA.0000000000002123.
    PubMed     Abstract available


    December 2016
  217. NITSCHKE P, Weitz J, Rahbari NN
    What Is the Impact of Intraoperative Re-resection After a Positive Pancreatic Margin Frozen Section in the Era of Perioperative Therapies?
    Ann Surg. 2016 Dec 30. doi: 10.1097/SLA.0000000000002130.
    PubMed    


  218. ABBOTT DE, Sutton JM, Jernigan PL, Chang A, et al
    How Much Should We Pay to Minimize Pancreatic Leak? The Cost-effectiveness of Pasireotide in Pancreatic Resection: RETRACTED.
    Ann Surg. 2016 Dec 30. doi: 10.1097/SLA.0000000000001411.
    PubMed     Abstract available


  219. KUTLU OC, Lee JE, Katz MH, Tzeng CD, et al
    Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population-based Analysis.
    Ann Surg. 2016 Dec 29. doi: 10.1097/SLA.0000000000002111.
    PubMed     Abstract available


  220. PETRUCCIANI N, Nigri G, Ramacciato G, Debs T, et al
    What Is the Impact of Intraoperative Reresection After a Positive Pancreatic Margin Frozen Section in the Era of Perioperative Therapies?
    Ann Surg. 2016.
    PubMed    


  221. WELLNER UF, Bolm L, Keck T
    Reply to: "Half the truth is Often a Great Lie: Over a Hundred Years of Controversy on Pancreatic Fistula Between Pancreaticogastrostomy and Pancreaticojejunostomy After Pancreaticoduodenectomy".
    Ann Surg. 2016.
    PubMed    


    November 2016
  222. TATARIAN T, Jiang W, Leiby BE, Grigoli A, et al
    Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial.
    Ann Surg. 2016.
    PubMed     Abstract available


  223. YIN Z, Jin H, Jian Z
    Half the Truth is Often a Great Lie: Over a Hundred Years of Controversy on Pancreatic Fistula Between Pancreaticogastrostomy and Pancreaticojejunostomy After Pancreaticoduodenectomy.
    Ann Surg. 2016.
    PubMed    


  224. KILAMBI R, Singh AN
    Randomized Controlled Trial of Pancreaticojejunostomy Versus Stapler Closure of the Pancreatic Stump During Distal Pancreatectomy to Reduce Pancreatic Fistula.
    Ann Surg. 2016.
    PubMed    


  225. TEIXEIRA UF, Goldoni MB, Waechter FL
    Pancreatic Fistula Following Distal Pancreatectomies: It's Better Not Looking for It.
    Ann Surg. 2016.
    PubMed    


  226. BANG JY, Wilcox CM, Navaneethan U, Hasan MK, et al
    Impact of Disconnected Pancreatic Duct Syndrome on the Endoscopic Management of Pancreatic Fluid Collections.
    Ann Surg. 2016.
    PubMed     Abstract available


  227. NELL S, Borel Rinkes IH, Verkooijen HM, Bonsing BA, et al
    Early and Late Complications After Surgery For MEN1-related Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2016.
    PubMed     Abstract available


  228. KAWAI M, Yamaue H
    Reply to Letter to the Editor "Pancreatic Fistula Following Distal Pancreatectomies. It's better Not Looking for It".
    Ann Surg. 2016.
    PubMed    


  229. MANRAI M, Kochhar R, Gupta V, Yadav TD, et al
    Outcome of Acute Pancreatic and Peripancreatic Collections Occurring in Patients With Acute Pancreatitis.
    Ann Surg. 2016.
    PubMed     Abstract available


    October 2016
  230. CERULLO M, Gani F, Chen SY, Canner JK, et al
    Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer.
    Ann Surg. 2016.
    PubMed     Abstract available


  231. KAWAI M, Yamaue H
    Reply to: The Letter to the Editor "Randomized Controlled Trial of Pancreaticojejunostomy versus Stapler Closure of the Pancreatic Stump During Distal Pancreatectomy to Reduce Pancreatic Fistula".
    Ann Surg. 2016.
    PubMed    


    September 2016
  232. ATTIYEH MA, Fernandez-Del Castillo C, Al Efishat M, Eaton AA, et al
    Development and Validation of a Multi-Institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
    Ann Surg. 2016 Sep 20. doi: 10.1097/SLA.0000000000002015.
    PubMed     Abstract available


  233. YEO CJ
    Invited Commentary: Pasireotide and the Prevention of Pancreatic Fistula After Pancreatectomy: "The Continued Search for Harry Potter's Liquid Luck".
    Ann Surg. 2016.
    PubMed    


    April 2016
  234. STROBEL O, Hank T, Hinz U, Bergmann F, et al
    Pancreatic Cancer Surgery: The New R-status Counts.
    Ann Surg. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: